Zacks Investment Research upgraded shares of ABCAM PLC/ADR (OTCMKTS:ABCZY) from a sell rating to a hold rating in a report released on Monday.

According to Zacks, “Abcam PLC distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam PLC is headquartered in Cambridge, the United Kingdom. “

Shares of ABCAM PLC/ADR stock opened at $15.74 on Monday. ABCAM PLC/ADR has a one year low of $12.75 and a one year high of $20.29.

The business also recently disclosed a Semi-Annual dividend, which will be paid on Friday, December 14th. Investors of record on Friday, November 9th will be given a dividend of $0.091 per share. This is an increase from ABCAM PLC/ADR’s previous Semi-Annual dividend of $0.04. The ex-dividend date is Thursday, November 8th.


Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, and tools and reagents.

See Also: Bear Market – How and Why They Occur

Get a free copy of the Zacks research report on ABCAM PLC/ADR (ABCZY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for ABCAM PLC/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABCAM PLC/ADR and related companies with's FREE daily email newsletter.